Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Troglitazone: a new antihyperglycemic agent

D G Vidt1, R A Speerhas, S S Reddy

  • 1Cleveland Clinic, Cleveland Clinic Foundation, OH 44195, USA.

Cleveland Clinic Journal of Medicine
|May 1, 1997
PubMed
Summary

Troglitazone is a novel antihyperglycemic medication. This review covers its practical applications in patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing mental and physical fatigue in major abdominal surgery by incorporating muscle stretches and hydration mini breaks.

Annals of the Royal College of Surgeons of England·2025
Same author

Intra-articular Steroid alone vs Hydrodilatation with intra-articular Steroid in Frozen Shoulder - A Randomised Control Trial.

Malaysian orthopaedic journal·2023
Same author

Is dosimetry still a necessity in current dental practice?

Journal of radiological protection : official journal of the Society for Radiological Protection·2015
Same author

Echocardiography guided therapy for myocarditis after scorpion sting envenomation.

Journal of clinical and diagnostic research : JCDR·2014
Same author

A Prospective Real World Experience of Moxonidine Use in Indian Hypertensive Patients-Prescription beyond Current Guidelines.

Journal of clinical and diagnostic research : JCDR·2013
Same author

Setting up a quality assurance model for newborn care to strengthen health system in Bihar, India.

Indian pediatrics·2013

Area of Science:

  • Pharmacology
  • Endocrinology
  • Internal Medicine

Background:

  • Troglitazone represents a new class of antihyperglycemic agents.
  • The drug targets specific pathways involved in glucose regulation.

Purpose of the Study:

  • To review the clinical utility of troglitazone.
  • To provide insights into its application in managing hyperglycemia.

Main Methods:

  • Literature review of clinical studies and practice guidelines.
  • Analysis of efficacy and safety data from published trials.

Main Results:

  • Troglitazone demonstrated effectiveness in lowering blood glucose levels.
  • Clinical practice data informed its therapeutic positioning.

Conclusions:

  • Troglitazone offers a new therapeutic option for antihyperglycemic management.
  • Its integration into clinical practice requires careful consideration of patient profiles.

Related Experiment Videos